Utah Medical Products
UTMD
88 hedge funds and large institutions have $229M invested in Utah Medical Products in 2018 Q4 according to their latest regulatory filings, with 11 funds opening new positions, 32 increasing their positions, 32 reducing their positions, and 13 closing their positions.
0% more repeat investments, than reductions
Existing positions increased: 32 | Existing positions reduced: 32
1.48% less ownership
Funds ownership: 74.76% → 73.28% (-1.5%)
2% less funds holding
Funds holding: 90 → 88 (-2)
13% less capital invested
Capital invested by funds: $263M → $229M (-$33.9M)
15% less first-time investments, than exits
New positions opened: 11 | Existing positions closed: 13
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RHJA
Rice Hall James & Associates
San Diego,
California
|
+$1.78M |
| 2 |
Marshall Wace
London,
United Kingdom
|
+$822K |
| 3 |
BlackRock
New York
|
+$772K |
| 4 |
CEP
Chicago Equity Partners
Chicago,
Illinois
|
+$635K |
| 5 |
Lazard Asset Management
New York
|
+$581K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AA
Ancora Advisors
Cleveland,
Ohio
|
-$1.93M |
| 2 |
Invesco
Atlanta,
Georgia
|
-$1.49M |
| 3 |
PPA
Parametric Portfolio Associates
Seattle,
Washington
|
-$1.18M |
| 4 |
ACM
Ativo Capital Management
Chicago,
Illinois
|
-$1.13M |
| 5 |
Russell Investments Group
London,
United Kingdom
|
-$1.03M |
UTMD Hedge Fund Activity: Q4 2018 in Review
88 of the 4,489 institutional investors tracked by Wall St. Rank reported a position in Utah Medical Products (UTMD) for Q4 2018, worth a combined $229M — down 13% from $263M a quarter earlier.
Sellers outnumbered buyers: 13 funds closed out of UTMD and 11 opened new positions — a net loss of 2 holders — while 32 trimmed existing stakes and 32 added.
The largest buyer was Rice Hall James & Associates, adding an estimated $1.78M. The largest seller was Ancora Advisors, cutting an estimated $1.93M.
- 88 institutional investors held Utah Medical Products (UTMD) as of Q4 2018, down from 90 in Q3 2018.
- Funds reported $229M of Utah Medical Products stock for Q4 2018, down 13% quarter-over-quarter.
- 11 funds opened new Utah Medical Products positions in Q4 2018 and 13 closed out, a net change of -2 holders.
- The largest Utah Medical Products buyer in Q4 2018 was Rice Hall James & Associates, an estimated $1.78M added.
- The largest Utah Medical Products seller in Q4 2018 was Ancora Advisors, an estimated $1.93M sold.
Based on aggregated 13F filings for Q4 2018.